De to af undersøgelserne omfattede 1 568 patienter med komplicerede infektioner i bughulen (af hvilke halvdelen var kompliceret blindtarmsbetændelse), og Tygacil blev her sammenlignet med imipenem/ cilastatin.
Two studies were in 1,568 patients with complicated intra-abdominal infections (half of those were complicated appendicitis), where Tygacil was compared with imipenem/ cilastatin.